Podcasts about carbapenem

In this episode of Infection Control Matters, Martin Kiernan speaks with Dr. Nicole Stoesser about a large-scale, multi-centre study exploring the role of hospital sink infrastructure in antimicrobial resistance and pathogen dissemination. Representing the collaborative NITCAR-led "Sinkbug Consortium" we discuss surprising findings from 29 UK hospitals—including widespread antibiotic residues in sink traps—and reflect on the implications for sink design, waste disposal practices, and infection prevention strategies The paper we discuss is here: Rodger G, Chau K, Aranega Bou P, Moore G, Roohi A, The SinkBug Consortium, et al. Survey of healthcare-associated sink infrastructure, and sink trap antibiotic residues and biochemistry, in 29 UK hospitals. J Hosp Infect 2025. https://doi.org/10.1016/j.jhin.2025.02.002. Information on Nitcar: https://nitcollaborative.org.uk/wp/ Other papers of interest: Aranega-Bou P, George RP, Verlander NQ, Paton S, Bennett A, Moore G, et al. Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system. J Hosp Infect 2019;102(1):63-9. https://doi.org/10.1016/j.jhin.2018.12.007 Grabowski M, Lobo JM, Gunnell B, Enfield K, Carpenter R, Barnes L, et al. Characterizations of handwashing sink activities in a single hospital medical intensive care unit. J Hosp Infect 2018;100(3):e115-e22. https://doi.org/10.1016/j.jhin.2018.04.025

In this episode of Infection Control Matters, Martin Kiernan speaks with Dr. Nicole Stoesser about a large-scale, multi-centre study exploring the role of hospital sink infrastructure in antimicrobial resistance and pathogen dissemination. Representing the collaborative NITCAR-led "Sinkbug Consortium" we discuss surprising findings from 29 UK hospitals—including widespread antibiotic residues in sink traps—and reflect on the implications for sink design, waste disposal practices, and infection prevention strategies The paper we discuss is here: Rodger G, Chau K, Aranega Bou P, Moore G, Roohi A, The SinkBug Consortium, et al. Survey of healthcare-associated sink infrastructure, and sink trap antibiotic residues and biochemistry, in 29 UK hospitals. J Hosp Infect 2025. https://doi.org/10.1016/j.jhin.2025.02.002. Information on Nitcar: https://nitcollaborative.org.uk/wp/ Other papers of interest: Aranega-Bou P, George RP, Verlander NQ, Paton S, Bennett A, Moore G, et al. Carbapenem-resistant Enterobacteriaceae dispersal from sinks is linked to drain position and drainage rates in a laboratory model system. J Hosp Infect 2019;102(1):63-9. https://doi.org/10.1016/j.jhin.2018.12.007 Grabowski M, Lobo JM, Gunnell B, Enfield K, Carpenter R, Barnes L, et al. Characterizations of handwashing sink activities in a single hospital medical intensive care unit. J Hosp Infect 2018;100(3):e115-e22. https://doi.org/10.1016/j.jhin.2018.04.025

On episode #62 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 8/15/24 – 8/28/24. Host: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Clinician Specialty and HIV PrEP Prescription Reversals and abandonments (JAMA Network: JAMA Internal Medicine) The association between adherence to antiretroviral therapy and viral suppression under dolutegravir-based regimens (JIAS Journal of the International AIDS Society) Dexamethasone in adults with viral meningitis (CMI Clinical Microbiology and Infection) Oropouche Virus Disease Among U.S. Travelers — United States, 2024 (MMWR) Oropouche fever, the mysterious threat (LANCET: Infectious Diseases) Bacterial High rates of Non-susceptibility to common oral antibiotics in Streptococcus pneumoniae clinical isolates (OFID) New York State Department of Health Directs Providers to Discontinue Use of Ciprofloxacin to Prevent Meningococcal Disease Due to Increasing Antimicrobial Resistance (NY State: Department of Health) Tularemia Associated with Harbor Seal Necropsy — Kitsap County, Washington, October 2023 (MMWR) FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis (FDA) Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia (CID) The Role of the Gut, Urine and Vaginal Microbiome on the Pathogenesis of Urinary Tract Infection (OFID) Fungal The Last of US Season 2 (YouTube) Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan (LANCET Infectious disease) Parasitic Usefulness of real-time PCR for urogenital schistosomiasis in preschool children in Angola (PLoS Neglected Tropical Diseases) Helminth infection driven gastrointestinal hypermotility alterations in smooth muscle instead of enteric neurons (PLoS Pathogens) Die-off reaction of Demodex mites after treating demodicosis with oral ivermectin (JAAD case reports) Miscellaneous Prevalence of carbapenem-resistant gram negative bacteria among neonates suspected for sepsis in Africa (BMC Infectious Diseases) New era of targeted clinical guidelines: IDSA (CID) Defining the landscape of educational experiences in transplant infectious diseases (OFID) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

In this podcast, I talk about how we used Oxford Nanopore Technologies' MinION device to track an outbreak of multi-drug resistant organisms in a hospital. All my posts have links to online resources that you might find useful, and ⁠⁠you can find the link to this particular blog here⁠⁠⁠⁠.

In this episode of The SHEA Podcast, SHEA Journal Club Chair and moderator Hannah Imlay is joined by guests Jennifer Cihlar and David Cluck to discuss two of the most impactful articles reviewed by the journal club this year. The first article, "Bacteremia From a Presumed Urinary Source in Hospitalized Adults With Asymptomatic Bacteriuria" by Advani SD, Ratz D, Horowitz JK, et al., examines the clinical implications of asymptomatic bacteriuria in hospitalized adults. The second article, "Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study" by Soto CL, Hsu AJ, Lee JH, et al., explores optimal antibiotic treatment durations for these challenging infections. Join us for an in-depth discussion on the findings and clinical impacts of these studies.

In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:Burden of CRE infections in the United StatesMechanisms of resistanceChanging epidemiologyUse of rapid diagnostic testsIDSA guidance recommendations, including supporting dataApproach to designing treatment regimens, including weighing patient- and infection-related factorsFaculty:Julie Ann Justo, PharmD, MS, FIDSA, BCPSClinical Pharmacist Lead – Infectious DiseasesInpatient PharmacyDartmouth Hitchcock Medical CenterLebanon, New HampshireLink to full program: https://bit.ly/41a8Mj0Link to accompanying ClinicalThought commentary:https://bit.ly/4865T57Link to downloadable infographic: https://bit.ly/3t7NpT2

In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:Burden of CRE infections in the United StatesMechanisms of resistanceChanging epidemiologyUse of rapid diagnostic testsIDSA guidance recommendations, including supporting dataApproach to designing treatment regimens, including weighing patient- and infection-related factorsFaculty:Julie Ann Justo, PharmD, MS, FIDSA, BCPSClinical Pharmacist Lead – Infectious DiseasesInpatient PharmacyDartmouth Hitchcock Medical CenterLebanon, New HampshireLink to full program: https://bit.ly/41a8Mj0Link to accompanying ClinicalThought commentary:https://bit.ly/4865T57Link to downloadable infographic: https://bit.ly/3t7NpT2

In this episode, Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections involving carbapenem-resistant Acinetobacter baumannii (CRAB), including: Mechanisms for β-lactam resistanceAdditional resistance mechanisms and virulence factors2023 IDSA guidance recommendations for moderate to severe CRAB infectionsThe latest clinical data by antimicrobial therapy/regimen:SulbactamMeropenem and colistinCarbapenem, sulbactam, and polymyxin BTetracyclinesCefiderocolSulbactam/durlobactam and carbapenems Program Director:Trevor Van Schooneveld, MD, FSHEA, FACP Professor, Division of Infectious DiseasesProgram Director, Infectious Diseases FellowshipMedical Director, Antimicrobial Stewardship ProgramUniversity of Nebraska Medical CenterOmaha, NebraskaFaculty:Emily Heil, PharmD, MS, BCIDP, AAHIVPAssociate ProfessorDepartment of PharmacyUniversity of Maryland School of PharmacyID Clinical Pharmacy SpecialistUniversity of Maryland Medical CenterBaltimore, MarylandLaila Woc-Colburn, MDAssociate ProfessorDivision of Infectious DiseasesEmory University School of Medicine Atlanta, GeorgiaContent based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program: https://bit.ly/40Mmicz

On episode #36 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 8/17 – 8/30/23. Host: Daniel Griffin Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode Detection of rotavirus in respiratory specimens from children aged under 2 years hospitalized for acute gastroenteritis (JID) Risk of Bell's palsy following SARS-CoV-2 infection (CMI) Evaluation and management of diabetes-related foot infections (CID) Impact of mandatory infectious disease specialist approval on Clostridioides difficile infection rates and testing appropriateness (CID) Role of cerebral imaging on diagnosis and management in patients with suspected infective endocarditis (CID) Identifying effective durations of antibiotic therapy for the treatment of carbapenem-resistant Enterobacterales bloodstream infections (CID) Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia (CMI) State-of-the-art review: Neurosyphilis (CID) Oritavancin compared to the standard of care for treatment of non-endovascular gram-positive bloodstream Infections (OFID) How to approach suppressive antibiotic therapy following debridement, antibiotics, and implant retention for prosthetic joint infection (CID) 2023 Duke-International Society for cardiovascular infectious diseases criteria for infective endocarditis (CID) Adjunctive diagnostic studies completed following detection of candidemia in children (JPIDS) Oral lipid nanocrystal amphotericin b for cryptococcal meningitis (CID) Efficacy of 23 commonly used liquid disinfectants against Candida auris (IC&HE) Burrow ink test for scabies (NEJM) Evolution of partial resistance to artemisinins in malaria parasites in Uganda (NEJM) Human neural larva migrans caused by Ophidascaris robertsi ascarid (EID) Music is by Ronald Jenkees

One Health is a concept which described the health not only of humans, but also of the envionment and animals. Our Guest, Dr Yogandree Ramsamy tells us about its origins, who governs the principles and how it can be applied to antimicrobial resistance and everyday clinical practice. About our Guest: Dr Yogandree Ramsamy, a medical doctor with a specialization in medical microbiology (MBChB, MMedPath (Microbiology), FCPath(SA)(Microbiology), PhD), is currently a Senior Pathologist in Medical Microbiology at JDJ Diagnostics. As a recipient of the One Health AMR Fellowship from the Université Paris Cité and Fondation Mérieux, the Institut Mérieux-ICAN Young Investigator Award in antimicrobial resistance (AMR), the L'Oreal-UNESCO for Women in Science Award and the SEDRIC-Wellcome Trust Travel Scholarship, Dr Ramsamy is extremely passionate about AMR and implementation of antimicrobial stewardship programs (ASPs). Currently a member of several local and international committees related to Antimicrobial Stewardship (AMS) and Infection Prevention and Control, Dr Ramsamy is committed to the fight against AMR. She has served on the provincial KZN Antimicrobial Stewardship (AMS) Committee, promoting the concept of AMR and AMS within the KZN public health sector in line with the South African National AMR Strategy. Her Master's focused on AMR, AMS and surveillance in the South African landscape and her PhD entailed investigating Carbapenem-resistant Enterobacterales (CRE) in a One Health context. She is a honorary research fellow in the Antimicrobial Research Unit at the University of KwaZulu-Natal. Her keen research interest in AMR, AMS and AMR surveillance has culminated in original research generating several publications + local and international conference presentations. Creating awareness of a bleak future without the prospects of lifesaving antimicrobials, mentoring up and coming individuals equally passionate about saving antimicrobials for future generations is one of her greatest ambitions.You can find Yogandree at:yogandree@gmail.comRamsamyy@ukzn.ac.zayogandree@jdj.co.za linkedin.com/in/yogandree-ramsamy-16a74a86Visit the Microbe Mail website to sign up for updates E-mail: mail.microbe@gmail.comYouTube: Microbe MailInstagram: Microbe_Mail

This week on Pharm5: Voluntary eyedrop recalls Bempedoic acid lowers MACE risk LDL

This week on Pharm5: Walmart, CVS Claim Pharmacist Shortage Changes to Paxlovid, Lagevrio, and COVID vaccines EzriCare eyedrops linked to bacterial outbreak New FDA approvals: Jayprica, Orserdu, Jesduvroq GoodRx sells health info to advertisers Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Valinsky J. CVS and Walmart Cut Pharmacy Hours, close some locations earlier, citing staffing shortage | CNN business. CNN. http://bit.ly/3RpgS2F. Published January 27, 2023. Accessed February 2, 2023. Keagy J. American Pharmacists Association on move to cut pharmacy hours. American Pharmacists Association. http://bit.ly/3JB0v0Q. Published January 30, 2023. Accessed February 2, 2023. Paxlovid, Lagevrio prescriptions no longer need a positive COVID-19 test. Becker's Hospital Review. http://bit.ly/3DC3Jh3. Published February 1, 2023. Accessed February 2, 2023. Fact sheet for healthcare providers: emergency use authorization for Paxlovid. New York, NY: Pfizer. https://bit.ly/3RvXNvO. Revised February 1, 2023. Accessed February 2, 2023. Fact sheet for healthcare providers: emergency use authorization for Lagevrio (molnupiravir) capsules). Rahway, NJ: Merck & Co. https://bit.ly/3HsLo72. Revised February 1, 2023. Accessed February 2, 2023. Bulloch M. FDA Advisory Committee vote to simplify covid-19 regimen. Pharmacy Times. http://bit.ly/3jweY3t. Published February 1, 2023. Accessed February 2, 2023. O'Mary L. Bacterial outbreak linked to EzriCare eyedrops: CDC. Medscape. http://bit.ly/3l3tOz9. Published February 1, 2023. Accessed February 2, 2023. Update: Multistate Cluster of VIM- and GES-producing Carbapenem resistant Pseudomonas aeruginosa associated with Artificial Tears. https://bit.ly/3DDHrey. Published January 20, 2023. Accessed February 2, 2023. Center for Drug Evaluation and Research. Novel drug approvals for 2023. U.S. Food and Drug Administration. http://bit.ly/3wO6ckC. Accessed February 2, 2023. Pagliarulo N. FDA approves cancer drugs from Lilly, Menarini. BioPharma Dive. http://bit.ly/3DEgnfc. Published January 30, 2023. Accessed February 2, 2023. FDA approves first oral treatment for anemia caused by chronic kidney disease for adults on dialysis. U.S. Food and Drug Administration. http://bit.ly/3RsL64E. Accessed February 2, 2023. FTC enforcement action to Bar Goodrx from sharing consumers' sensitive health info for advertising. Federal Trade Commission. http://bit.ly/3l50F6C. Published February 1, 2023. Accessed February 2, 2023.

Episode Notes This episode features Dr. Melissa Johnson from DASON. The article reviewed in this episode is available here: https://pubmed.ncbi.nlm.nih.gov/36601545/ For more information about DASON, please visit: https://dason.medicine.duke.edu Find out more at https://dason-digest.pinecast.co

In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including: The role of novel β-lactam/β-lactamase inhibitor combinationsUse of clinical predictions scores (eg, Drug Resistance in Pneumonia [DRIP] score) to predict risk for pneumonia caused by multidrug-resistant pathogensApplication of rapid diagnostic testing in critically ill patients with pneumonia, including current limitationsImplementation of advanced antibiograms and clinical prediction scoresClinical utility of biomarkers for pneumonia (eg, procalcitonin)Application of updated nosocomial pneumonia classifications in clinical practiceFaculty:Marion Elligsen, BScPhm, ​ MSc, RPh, ACPR​Practice-Based Researcher​Sunnybrook Research Institute​Antimicrobial Stewardship Pharmacy Lead​Department of Pharmacy​Sunnybrook Health Sciences Centre​Toronto, Ontario, Canada​Keith S. Kaye, MD, MPHChief  Division of Allergy, Immunology and Infectious DiseasesProfessor of MedicineRutgers Robert Wood Johnson Medical SchoolNew Brunswick, New JerseyAndrew Shorr, MD, MPH, MBA​Director​Pulmonary and Critical Care Medicine​Medstar Washington Hospital Center​Washington, DC​Content based on a CME program supported by an educational grant from Merck Sharp & Dohme Corp. Link to full program:https://bit.ly/3HaZpYwLink to downloadable slideset:https://bit.ly/3UxHoqr

- Việt Nam đang đối mặt với tình trạng kháng thuốc có xu hướng ngày càng tăng, với nhiều cấp độ khác nhau. Trong đó, xuất hiện tình trạng kháng kháng sinh của một số tác nhân gây bệnh thường gặp trong cơ sở y tế. Cụ thể tỷ lệ nhiễm vi khuẩn đường ruột kháng nhóm kháng sinh Carbapenem tăng từ 13% vào ngày bệnh nhân nhập viện lên gần 90% vào ngày thứ 15 nằm viện. Tại Hội thảo " Kháng kháng sinh, cơ hội và thách thức" sáng nay, tại Hà Nội, Bộ Y tế cho biết, đang xây dựng chiến lược quốc gia về phòng chống kháng kháng sinh giai đoạn 2022- 2030, tầm nhìn 2045 trình Chính phủ phê duyệt. Chủ đề : Xây dựng chiến lược, chống kháng kháng sinh --- Support this podcast: https://anchor.fm/vov1tintuc/support

Callum and Jame provide an overview of the Carbapenem class of antibiotics discussing: what they are; their spectrum of action (looking in particular at what they don't cover); resistance; how to use them; and side effects.This site has a useful summary of the new formulation of carbapenems and their spectra:http://www.microbiologynutsandbolts.co.uk/the-bug-blog/new-sweets-on-the-market-but-will-these-new-flavours-live-up-to-their-vibrant-coloursHere is the NEJM paper on Tebipenem Jame mentions:https://www.nejm.org/doi/full/10.1056/NEJMoa2105462Send suggestions to idiotspodcasting@gmail.com

Dr. Brian Locke is back to talk about that "nonrandomized" proning trial.  We also talk about the new oral carbapenem for UTI trial, whether 1-2 months of DAPT is non-inferior to 12 months of DAPT, whether less than 1500 mg of sodium reduces heart failure hospitalizations, the risk of anaphylaxis from IV iron, and whether pickle juice is effective for treating cramps in cirrhosis. Check it out! Oral Tebipenem vs IV Ertapenem for Complicated UTIAwake Proning for Hospitalized COVID-19 Patients1-2 Months of DAPT vs 12 months of DAPT vs ACSLow Sodium Diet for Heart FailureEstimating Excess Mortality due to COVID-19Risk of Anaphylaxis from IV Iron Pickle Juice for Cramps in CirrhosisMusic from Uppbeat (free for Creators!):https://uppbeat.io/t/soundroll/dopeLicense code: NP8HLP5WKGKXFW2R

Do you sometimes look at a Microbiology report and wonder if the microbiologist made up the tongue-twister of a microbe name you're reading on the report? In this episode, we unpack the differences between contaminants, commensals and colonisers in the common specimen types – urine, respiratory samples and blood cultures. Spotlight feature: mini microbe message Visit the Microbe Mail https://microbemail.captivate.fm/ (website) to sign up for updates E-mail: mail.microbe@gmail.com YouTube: https://www.youtube.com/channel/UCgaP3aUNkjrgOxR8Ei6UaEw (Microbe Mail) Instagram: https://instagram.com/https:/www.instagram.com/microbe_mail/ (Microbe_Mail)  Guest: Dr Yogandree Ramsamy   Dr Yogandree Ramsamy is a Clinical Microbiologist at Prince Mshiyeni Memorial Hospital in Umlazi, KwaZulu-Natal (KZN), South Africa. Dr Ramsamy is extremely passionate about AMR and implementation of antimicrobial stewardship programs (ASPs). Currently a member of several local and international committees related to Antimicrobial Stewardship (AMS) and Infection Prevention and Control, Dr Ramsamy is committed to the fight against AMR. Appointed by the Head of Health in KZN to serve on the KZN Antimicrobial Stewardship (AMS) Committee, Dr Ramsamy engages with various stakeholders to promote the concept of AMS within the KZN public health sector in line with the South African National AMR Strategy. As a lecturer and currently pursuing a PhD at the University of KwaZulu-Natal reviewing Carbapenem-resistant Enterobacterales (CRE) in a One Health perspective, she is passionate about making a difference and contributing to academic progress. Creating awareness of a bleak future without the prospects of lifesaving antimicrobials, mentoring up and coming individuals who are equally passionate about saving antimicrobials for future generations is one of her greatest ambitions.

This week, we discuss a strange and rare pseudomonas phenotype. Find out why these strains are resistant to carbapenems but usually not other antibiotics and the significance of these strains. Search "ER-Rx" on Apple Podcasts, Google Podcast, and YouTube. Also, check out our Instagram page: errxpodcast ! References:Gajdacas M. Carbapenem-resistant but cephalosporin-susceptible pseudomonas aeruginosa in urinary tract infections: opportunity for colistin sparing. Antibiotics. 2020; 9(4): 153.Li S, Jia X, Li C, et al. carbapenem-resistant but cephalosporin-susceptible pseudomonas aeruginosa; a notable phenotype in patients with bacteremia. Infect Drug Resist. 2018; 11: 1225-1335

"I really rely on the expertise of the team and I value input. I also value contradiction." - Ankit Mahadevia, founder and CEO of Spero Therapeutics

En el programa de esta semana concluimos por los momentos nuestra serie dedicada a la resistencia a los carbapenemicos hablando sobre  las opciones terapéuticas y específicamente sobre el tratamiento combinado de dos o mas drogas.   Referencias: Carrara E y colaboradores. Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Curr Op Infect Dis December 2018. 31(6):594-599. Ana Maria Peri y colaboradores. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagnostic Microbiology and Infectious Disease 94 (2019) 413–425. Yohei Doi. Treatment Options for Carbapenem-resistant Gramnegative Bacterial Infections. Clin Infect Dis 2019; 69(S7): S565-75.   La Frase de la Semana: Le pertenece esta semana a Charles Bukowski, poeta, novelitas, escritor de cuentos de origen agermano-americano nacido el 16 de agosto de 1920 en Alemania y fallecido el 9 de marzo de 1994 en los Ángeles, Estados Unidos. La Frase dice: “Estamos aquí para reírnos del destino y vivir tan bien nuestra vida que la muerte tiemble al recibirnos”  

Kieran Quinn is joined by Kevin Venus, fellow in General Internal Medicine at the University of Toronto, on this week's episode of The Rounds Table.  Together they cover the use of a carbapenem versus a carbapenem-sparing agent in resistant bacteremias and the efficacy of proton-pump inhibitors (PPIs) in preventing gastrointestinal bleeding when using anti-thrombotic therapy ... The post REPLAY: Bugs & Guts – Carbapenem-Sparing Agents in Resistant Infections and Omeprazole in Coronary Artery Disease appeared first on Healthy Debate.

Kieran Quinn is joined by Kevin Venus, fellow in General Internal Medicine at the University of Toronto, on this week's episode of The Rounds Table.  Together they cover the use of a carbapenem versus a carbapenem-sparing agent in resistant bacteremias and the efficacy of proton-pump inhibitors (PPIs) in preventing gastrointestinal bleeding when using anti-thrombotic therapy ...The post REPLAY: Bugs & Guts – Carbapenem-Sparing Agents in Resistant Infections and Omeprazole in Coronary Artery Disease appeared first on Healthy Debate.

Kieran Quinn is joined by Kevin Venus, fellow in General Internal Medicine at the University of Toronto, on this week's episode of The Rounds Table.  Together they cover the use of a carbapenem versus a carbapenem-sparing agent in resistant bacteremias and the efficacy of proton-pump inhibitors (PPIs) in preventing gastrointestinal bleeding when using anti-thrombotic therapy ... The post Bugs & Guts: Carbapenem-Sparing Agents in Resistant Infections and Omeprazole in Coronary Artery Disease appeared first on Healthy Debate.

Kieran Quinn is joined by Kevin Venus, fellow in General Internal Medicine at the University of Toronto, on this week's episode of The Rounds Table.  Together they cover the use of a carbapenem versus a carbapenem-sparing agent in resistant bacteremias and the efficacy of proton-pump inhibitors (PPIs) in preventing gastrointestinal bleeding when using anti-thrombotic therapy ...The post Bugs & Guts: Carbapenem-Sparing Agents in Resistant Infections and Omeprazole in Coronary Artery Disease appeared first on Healthy Debate.

This time on the ‘Gluten Free RN’ podcast, Nadine explores the connection between gluten intolerance and antibiotic-resistant threats. Because damaged intestines compromise the immune system, undiagnosed celiac patients are more likely to develop infections that necessitate antibiotics.  Nadine summarizes the 2013 CDC report, Antibiotic Resistance Threats in the United States, explaining the three microorganisms identified in the report with a Threat Level of Urgent. Listen and learn how to protect yourself and your family from the public health threat posed by these bacteria!  What’s Discussed:  The prevalence of undiagnosed celiac disease and gluten intolerance 30-50% of the population carry the HLA-DQ2 and/or DQ8 genes The importance of healthy intestinal tissue 70-90% of the immune system is in your intestines The soldier analogy Healthy villi are like rested soldiers with loaded weapons on a clear day who can easily take out antigens that don’t belong Damaged villi are like soldiers on a bender with inadequate weaponry, operating in smoke and fire – they either don’t work at all or fire randomly at antigens The need for a more judicious approach to prescribing antibiotics Overuse of antibiotics wipes out good microbiome along with bad How to rebuild microbiome Kombucha High-quality probiotics Fermented foods Apple cider vinegar The need for IgA and IgG testing to complement a celiac panel The public health threat posed by antibiotic-resistant bacteria The 2013 CDC report details 2 million illnesses and 23,000 deaths yearly The connection between damaged intestines and a higher risk of bacterial infection requiring antibiotics The three microorganisms with a Threat Level of Urgent Clostridium difficile (causes profuse diarrhea, 14,000 deaths/year) Carbapenem-resistant Enterobacteriaceae (50% fatal, 600 deaths/year) Neisseria gonorrhoeae The causes of inflammation in your intestines Gluten Dairy Sugar Why Nadine has concerns about the potential pandemic and huge loss of life presented by large numbers of undiagnosed celiac patients who are susceptible to bacterial infections  Resources Mentioned:   CDC Report: Antibiotic Resistance Threats in the United States, 2013 Enterolab Website Cyrex Laboratories Website PubMed Connect with Nadine:  Instagram Facebook Contact via Email Books by Nadine: Dough Nation: A Nurse's Memoir of Celiac Disease from Missed Diagnosis to Food and Health Activism

Join us as Dr. Hudson Garrett discusses effective ways being used to prevent acquiring a C. difficile infection (CDI) and Carbapenem-resistant Enterobacteriaceae (CRE), treatments available, and environmental safety - infection prevention in hospitals, long-term care, and at home. Dr. Garrett is a recognized international expert in infection prevention and control. Dr Garrett currently serves as the Chair of the Education Committee for the C Diff Foundation and is a graduate of the Johns Hopkins Fellows Program in Infection Control and Hospital Epidemiology. He was honored as a Who's Who for Infection Control by Infection Control Today Magazine in 2013 in recognition of his contributions to the field.

Join us as Dr. Hudson Garrett discusses effective ways being used to prevent acquiring a C. difficile infection (CDI) and Carbapenem-resistant Enterobacteriaceae (CRE), treatments available, and environmental safety - infection prevention in hospitals, long-term care, and at home. br Dr. Garrett is a recognized international expert in infection prevention and control. Dr Garrett currently serves as the Chair of the Education Committee for the C Diff Foundation and is a graduate of the Johns Hopkins Fellows Program in Infection Control and Hospital Epidemiology. He was honored as a Who's Who for Infection Control by Infection Control Today Magazine in 2013 in recognition of his contributions to the field.

Vincent, Elio, Michael, and Michele discuss the diel transcriptional rythmns of bacterioplankton communities in the ocean, and extensively drug resistant Pseudomonas in Ohio.

Vincent and Michael meet up with Ellen Jo Baron to talk about working in a clinical microbiology laboratory.

Thu, 27 Nov 2008 12:00:00 +0100 https://edoc.ub.uni-muenchen.de/9486/ https://edoc.ub.uni-muenchen.de/9486/1/Schlaf_Susanne.pdf Schlaf, Susanne ddc:540, ddc:500, Fakultät für Chemie und Pharmazie